US OptionsDetailed Quotes
AXDX250117P2500
- 0.85
- 0.000.00%
15min DelayClose Jan 3 16:00 ET
0.00High0.00Low
0.85Open0.85Pre Close0 Volume4 Open Interest2.50Strike Price0.00Turnover360.52%IV-22.22%PremiumJan 17, 2025Expiry Date1.15Intrinsic Value100Multiplier13DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7029Delta0.3686Gamma1.06Leverage Ratio-0.0118Theta-0.0007Rho-0.74Eff Leverage0.0009Vega
Accelerate Diagnostics Stock Discussion
Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System
An automated platform designed to fight against Sepsis and Antimicrobial Resistance (AMR)
Enables rapid, automated microbial identification on the Bruker MALDI Biotyper® CA System directly from positive blood culture samples
TUCSON, Ariz., Sept. 30, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an innovator of rapid in vitro diagnostics, announced that the U.S....
$Borealis Foods Inc. (BRLS)$: +98.75%.
$Snap Inc. (SNAP)$: Notable increase following positive news and potential regulatory changes.
$Mullen Automotive Inc. (MULN)$: Volatile with low float, ideal for day traders.
$TransCode Therapeutics, Inc. (RNAZ)$: +55.65% due to advances in biotechnology.
$Akso Health Group (AHG)$: +67.14%, with growth in the health sector.
$Accelerate Diagnostics, Inc. (AXDX)$: +56.46%, momentum in medical diagnostics.
$Bakkt Holdings, Inc. (B...
No comment yet